Rupak Banerjee

Dr. Rupak Banerjee


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
PRPrabir Roy-Chaudhury
Prabir Roy-Chaudhury
LALois Arend
Lois Arend
JZJianhua Zhang
Jianhua Zhang
MKMahesh Krishnamoorthy
Mahesh Krishnamoorthy
YWYang Wang
Yang Wang
RMRino Munda
Rino Munda

17 April 2009 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PRP. Roy-Chaudhury
P. Roy-Chaudhury
YWY. Wang
Y. Wang
MKM. Krishnamoorthy
M. Krishnamoorthy
JZJ. Zhang
J. Zhang
RBRupak Banerjee
Rupak Banerjee
LAL. Arend
L. Arend
Haemodialysis vascular access dysfunction (due to venous stenosis and thrombosis) is a leading cause of hospitalization and morbidity. The aim of the current study was to identify the specific cell types present within stenotic tissue samples from patients with AV fistula and graft failure. Discarded tissue segments were collected from the stenotic portions (usually near the graft-vein anastomosis or the AV anastomosis) of 23 dialysis grafts and 20 AV fistulae, and examined for expression of smooth muscle alpha actin, desmin, vimentin and a macrophage marker. The majority of cells within the venous neointima (both grafts and fistulae) were myofibroblasts, with a smaller number of desmin positive smooth muscle cells. The graft neointima had a similar cellular phenotype, albeit without any desmin positive contractile smooth muscle cells. The majority of cells within the PTFE graft material were macrophages. Analysis of sequential sections revealed the presence of fibroblasts within the venous neointima and intragraft region. Our results demonstrate that contractile smooth muscle cells, myofibroblasts, fibroblasts and macrophages all play a role in the pathogenesis of dialysis access dysfunction (grafts and fistulae). Targeting these specific cell types might result in the development of novel therapeutic paradigms for haemodialysis vascular access dysfunction.

30 October 2007 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
YWY. Wang
Y. Wang
MKM. Krishnamoorthy
M. Krishnamoorthy
RBRupak Banerjee
Rupak Banerjee
JZJ. Zhang
J. Zhang
SRS. Rudich
S. Rudich
PRP. Roy-Chaudhury
P. Roy-Chaudhury
Haemodialysis vascular access dysfunction is currently a huge clinical problem. Although arteriovenous (AV) fistulae are the preferred mode of dialysis access, they have significant problems with both early (failure to mature) and late fistula failure. Both are characterized radiologically as a stenosis of the venous segment. Despite the magnitude of the clinical problem, the exact pathogenesis of AV fistula failure remains unclear. The aim of this study was to develop and validate a pig model of AV fistula stenosis and then use it to dissect out the mechanisms responsible for this lesion. AV fistulae were created between the femoral artery and vein of Yorkshire Cross pigs. Animals were sacrificed at 2 days, 7 days, 28 days and 42 days post-surgery. At the time of sacrifice the entire specimen was divided into four regions; the arterial (AV-A) and venous (AV-V) portions of the AV anastomosis, the juxta-anastomotic segment (JA) and the proximal vein (PV), and assessed for the degree of intima-media thickening and the presence of specific cellular phenotypes. Haemodynamic parameters were not measured in this set of experiments. Significant luminal stenosis and intima-media thickening were present as early as 28 days and 42 days post-surgery in the pig model. In addition, within specimens from a single time point, these two parameters were maximal within the proximal vein and juxta-anastomotic segment as compared to the AV anastomosis (P < 0.0001). The vast majority of cells within the region of intima-media thickening were myofibroblasts. These studies suggest that early and aggressive intima-media thickening (which is made up primarily of myofibroblasts) plays an important role in AV fistula stenosis in a pig model of AV fistula placement. Interventions that target the mechanisms and cellular phenotypes described in this model, may be effective in reducing the very significant morbidity and economic costs currently associated with AV fistula failure.

10 January 2011 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
TLTimmy Lee
Timmy Lee
VCVibha Chauhan
Vibha Chauhan
MKMahesh Krishnamoorthy
Mahesh Krishnamoorthy
YWYang Wang
Yang Wang
LALois Arend
Lois Arend
PRPrabir Roy-Chaudhury
Prabir Roy-Chaudhury
Background. Venous neointimal hyperplasia is the most common cause of arteriovenous (AV) fistula and graft dysfunction following dialysis access surgery. However, the pathogenetic impact of pre-existing venous neointimal hyperplasia at the time of AV access creation on final clinical success is currently unknown in the setting of advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients. The aim of this study was to perform a detailed histological, morphometric, and immunohistochemical analysis of vein specimens in advanced CKD and ESRD patients collected at the time of new vascular access placement. Methods. Vein samples from 12 patients were collected at the time of AV access creation near the site of AV anastomosis. Histological, immunohistochemistry and morphometric studies were performed on these vein samples. Results. Examination of the tissue specimens obtained at the time of surgery showed neointimal hyperplasia in 10 of 12 specimens, ranging from minimal to very severe. The majority of cells within the neointima were myofibroblasts with a minority of contractile smooth muscle cells present. Conclusion. Our work represents a detailed description of the morphometric and cellular phenotypic lesions present in the veins of CKD and ESRD patients, prior to dialysis access placement. These studies (i) suggest the future possibility of a new predictive marker (pre-existing venous neointimal hyperplasia) for AV dialysis access dysfunction and (ii) open the door for the future development of novel local therapies for optimization of the venous substrate on which the dialysis access is created.

1 July 2005 in Journal of Controlled Release
Verified
Journal Article
Closed access
JPJuyoung Park
Juyoung Park
PBPeter M. Bungay
Peter M. Bungay
RLRobert J. Lutz
Robert J. Lutz
JAJames J. Augsburger
James J. Augsburger
RMRonald W. Millard
Ronald W. Millard
RBRupak Banerjee
Rupak Banerjee

1 December 2008 in Kidney International
Verified
Journal Article
Closed access
MKMahesh K. Krishnamoorthy
Mahesh K. Krishnamoorthy
RBRupak Banerjee
Rupak Banerjee
YWYang Wang
Yang Wang
JZJianhua Zhang
Jianhua Zhang
ARAbhijit Sinha Roy
Abhijit Sinha Roy
PRPrabir Roy-Chaudhury
Prabir Roy-Chaudhury